Tag Archives: Virginia

Research!America Honors Congressmen Frank Wolf and Chaka Fattah for Advancing Medical Innovation to Save Lives and Strengthen the Economy

Reps. Wolf and Fattah to Receive the Edwin C. Whitehead Award for Medical Research Advocacy at Research!America’s Advocacy Awards Dinner on March 12

ALEXANDRIA, Va.February 12, 2014-Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA) will receive the Edwin C. Whitehead Award for Medical Research Advocacy for their leadership and unwavering commitment to supporting policies that promote federal and private sector medical research and innovation. Reps. Wolf and Fattah have spearheaded efforts to create a legislative and regulatory climate conducive to medical innovation.

“Representatives Wolf and Fattah are exceptional champions for research,” said Research!America Chair John Edward Porter. “They have worked vigorously to increase funding for research, support policies that ignite public and private sector innovation, maintain our global competitiveness, and help patients and their families struggling with costly and debilitating diseases.”

Wolf is currently a senior member of the House Appropriations Committee, presides as chairman of the Commerce, Justice, Science Subcommittee, and is a member of the Transportation, Housing and Urban Development and State and Foreign Operations subcommittees. Throughout his distinguished tenure in Congress, Wolf has worked to advance the state of science and R&D, and he recognizes the role innovation plays in our nation’s economy, health and international competitiveness. Notably, he was a founder of the “Rising Above the Gathering Storm” Commission which sparked a national effort to bolster federal science, technology, engineering and mathematics (STEM) education and R&D programs. These efforts culminated in the enactment of the first America COMPETES Act in 2007 to increase public-private partnerships and provide assistance to innovators throughout the country. Wolf also supported the act’s reauthorization in 2010. He is an active member of several caucuses, including research and development, Parkinson’s, Alzheimer’s and multiple sclerosis. Continue reading →

Advertisements

Global Disparities in Tuberculosis Treatment Highlight Need for More Research

We are reminded yet again why global health issues matter for Americans with recent news coverage of a possible tuberculosis outbreak at a Virginia high school that may have affected over 430 faculty and students. Health officials are recommending that all individuals at the school be tested for the disease.

Courtesy of CDC/ Dr. Ray Butler

Tuberculosis bacteria
Photo credit: CDC/ Dr. Ray Butler

Historically, tuberculosis has been the world’s greatest infectious killer, taking an estimated billion lives over the past 200 years. Tuberculosis remains a global threat today – in 2011 alone, the disease sickened 8.7 million people. Even more alarming is the rise of drug-resistant forms of the disease. WHO estimates that more than 5% of TB patients worldwide have multidrug resistant (MDR) TB, meaning that typical frontline drugs will not be effective. Because it is often expensive to test for drug-resistance, only a handful of patients are appropriately diagnosed so many experts estimate that this number may be even higher. Doctors are also discovering cases of extensively drug resistant (XDR) TB in which patients do not respond to a majority of existing drugs. Continue reading →